Doctors without Borders asks J&J not to enforce secondary patents for TB drug after generic deal with nonprofit

Doctors without Borders criticized a deal between Johnson & Johnson and the Stop TB Partnership that allows the Swiss nonprofit to manufacture and supply generic forms of J&J’s tuberculosis drug, Sirturo.

The patent for Sirturo, or bedaquiline, expired Tuesday in multiple countries, according to Médecins Sans Frontières (MSF), the medical advocacy group also known as Doctors Without Borders.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy – Biotech Investments

New York, 10/09/2024 / 14:01, EST/EDT – EQS Newswire – Laxxon Medical NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical, a

October 10, 2024

Happening in Springfield: New immigrants offer economic promise, health system challenges

When Republican vice presidential candidate JD Vance claimed Haitian immigrants had caused infectious-disease rates to “skyrocket” in Springfield, Ohio, local health commissioner Chris Cook checked

October 10, 2024

Takeda’s Entyvio receives FDA approval for subcutaneous dose

The treatment is indicated for use in moderately to severely active ulcerative colitis in adults. Credit: mi_viri/Shutterstock.com. Takeda has received approval from the US Food

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.